Evidence
Proven in peer-reviewed clinical research.
Not marketing claims. Published in leading journals and validated in IRB-approved studies. Clinical validation this rigorous is rare in healthcare AI.
Outcomes
The numbers behind the claims
Drawn from peer-reviewed publications and our own deployments. Every figure traces back to a study and a sample size.
Fewer provider interactions
Patient satisfaction
Results clarity
Knowledge transfer
Would recommend to family
Provider time per case
More patients seen
Sources: npj Digital Medicine (2025), ACMG (2023), and
deployment data.
Publications
Peer-reviewed & presented
Published in leading journals and presented at clinical conferences, with full citations and sample sizes.

Effectiveness of the digital avatar for carrier screening
An IRB-approved carrier-screening study reported 87.2% knowledge transfer, 95% of patients feeling informed enough to decide, and a 4.3/5 satisfaction rating.

Expanded targeted preconception carrier-screening panel
A 10,115-patient study found pan-ethnic screening identified roughly 4× more at-risk couples than ethnicity-based screening (2.6% vs. 0.7%).
In their words
What clinical teams say
Anonymized feedback from the labs and health systems running Igentify at scale.
“The Igentify solution improves our team's efficiency from an operational perspective.”
“Igentify allows us to care for more patients without compromising on quality of care.”
“The process simulates the face-to-face genetic counseling experience very well, and saves time without compromising on quality.”
Scale
patients guided through their results and care, at national-lab scale.
Backed by a multi-year enterprise partnership with a leading US national laboratory.
Trust & compliance
Built to the standard of care
A regulated medical device. A familiar anchor for compliance and legal teams.




EU recognition
Three EU Horizon 2020 Seals of Excellence
Independent European Commission review awarded
a Seal of Excellence on three proposals. View or download each certificate.
Put the evidence to work.
See how these outcomes translate to your indications and patients.


